AI Science Tracker
EN

Learned multi-omics panel is evaluated against pediatric pneumonia severity

Shenzhen University; Shenzhen Nanshan People's Hospital · 31 Jan 2026 · medicine

Discovery

Learned multi-omics panel is evaluated against pediatric pneumonia severity

Source check: Source checked. Not independent scientific confirmation.

Finding: A learned eight-feature panel combined five protein and three metabolite measurements to distinguish mild from severe pediatric pneumonia. The source reports an ROC area of 0.82 in a further 50 clinical samples. This is severity-label discrimination, not mortality prediction, a demonstrated early forecast or a treatment effect.

Technology: Random-forest feature ranking; logistic regression

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The Results attribute feature ranking to a random-forest model, while the Methods describe the selected five-protein/three-metabolite panel entering a logistic classifier. AI credit is limited to learned panel nomination/evaluation, not pathways or treatment mechanisms.
Test and result
Initial recruitment comprised 57 affected children and 10 healthy controls. The source describes a 70:30 development/test split and a separate 50-sample clinical validation for the severity panel, with reported AUC 0.82.
Limitation / still unknown
Exact model ordering differs between Results and Methods and is not fully reconciled. Matched multi-omics sample counts, repeated-sample independence and additional cohort timing/composition are incompletely specified in reviewed passages. Some redundancy filtering is described before the split. Validation is retrospective and single-centre, not an established independently frozen clinical test. A heading mentions mortality, but modeled labels are mild versus severe disease. Operational laboratory/pathogen procedures were not inspected.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12925244/ · https://doi.org/10.1016/j.isci.2026.114861

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Original selected computational/clinical or physical Methods, model role, specific Results and limitations read; operational biological sections excluded.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.